AKT1 and lung adenocarcinoma: In lung adenocarcinoma (LAD) tissues and cell lines, the PI3K/AKT signaling pathway is significantly activated, while silencing TP73-AS1 expression markedly suppresses its activity, suggesting that TP73-AS1 may promote LAD progression by activating the PI3K/AKT pathway [13].